Higher minor hemoglobin A2 levels in multiple sclerosis patients correlate with lesser disease severity


Ozcan M. E., Ince B., Karadeli H. H., Gedikbasi A., Asil T., Altinoz M. A.

NEUROPSYCHIATRIC DISEASE AND TREATMENT, cilt.12, ss.2033-2038, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 12
  • Basım Tarihi: 2016
  • Doi Numarası: 10.2147/ndt.s109954
  • Dergi Adı: NEUROPSYCHIATRIC DISEASE AND TREATMENT
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2033-2038
  • Anahtar Kelimeler: multiple sclerosis, erythrocytes, adult minor hemoglobin, hemoglobin A2, BETA-GLOBIN, ERYTHROPOIESIS, EXPRESSION, HYPOTHESIS, THERAPY, SCREEN
  • İstanbul Üniversitesi Adresli: Evet

Özet

Objective: To define whether minor adult hemoglobin A2 (HbA2, alpha 2 delta 2) exerts any protective activity in multiple sclerosis (MS).